메뉴 건너뛰기




Volumn 6, Issue 4, 2009, Pages 345-347

Treatment of metronidazole-resistant Trichomonas vaginalis

Author keywords

Compounding pharmacy; Nonoxynol 9; Tinidazole; Topical furazolidone.

Indexed keywords

FURAZOLIDONE; METRONIDAZOLE; PAROMOMYCIN; TINIDAZOLE;

EID: 70450201051     PISSN: 14485028     EISSN: None     Source Type: Journal    
DOI: 10.1071/SH09064     Document Type: Article
Times cited : (24)

References (12)
  • 1
    • 17444448942 scopus 로고    scopus 로고
    • Trichomonas vaginalis associated with low birth weight and preterm delivery
    • The Vaginal Infections and Prematurity Study Group doi: 10.1097/ 00007435-199707000-199800008
    • Cotch MF, Pastorek JG 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis 1997; 24: 353-60. doi: 10.1097/ 00007435-199707000-199800008
    • (1997) Sex Transm Dis , vol.24 , pp. 353-360
    • Cotch, M.F.1    Pastorek Ii, J.G.2    Nugent, R.P.3    Hillier, S.L.4    Gibbs, R.S.5    Martin, D.H.6
  • 2
    • 1542572794 scopus 로고    scopus 로고
    • Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis
    • DOI 10.1038/sj.cr.7290169, PII 7290169
    • Dunne R, Dunn L, Upcroft P, O'Donoghue P, Upcroft J. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res 2003; 13: 239-249 doi: 10.1038/sj.cr.7290169 (Pubitemid 43225253)
    • (2003) Cell Research , vol.13 , Issue.4 , pp. 239-249
    • Dunne, R.L.1    Dunn, L.A.2    Upcroft, P.3    O'Donoghue, P.J.4    Upcroft, J.A.5
  • 3
    • 0035138734 scopus 로고    scopus 로고
    • Drug targets and mechanisms of resistance in the anaerobic protozoa
    • DOI 10.1128/CMR.14.1.150-164.2001
    • Upcroft P, Upcroft JA. Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin Microbiol Rev 2001; 14: 150-164 doi: 10.1128/CMR.14.1.150-164.2001 (Pubitemid 32096211)
    • (2001) Clinical Microbiology Reviews , vol.14 , Issue.1 , pp. 150-164
    • Upcroft, P.1    Upcroft, J.A.2
  • 4
    • 0037052352 scopus 로고    scopus 로고
    • Sexually transmitted diseases treatment guidelines 2002
    • No.. [See also]
    • Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep 2002; 51: No.. [See also www.cdc.gov/std]
    • (2002) MMWR Recomm Rep , pp. 51
  • 5
    • 0033595122 scopus 로고    scopus 로고
    • Metronidazole-resistant vaginal trichomoniasis an emerging problem
    • Sobel JD, Nagappan V, Nyierjesy P. Metronidazole-resistant vaginal trichomoniasis an emerging problem. N Engl J Med 1999; 341: 292-293
    • (1999) N Engl J Med , vol.341 , pp. 292-293
    • Sobel, J.D.1    Nagappan, V.2    Nyierjesy, P.3
  • 6
    • 33845266217 scopus 로고    scopus 로고
    • Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole
    • Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother 2006; 50: 4209-4210
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 4209-4210
    • Schwebke, J.R.1    Barrientes, F.J.2
  • 7
    • 0034951287 scopus 로고    scopus 로고
    • Prevalence of metronidazole resistant Trichomonas vaginalis in a gynecology clinic
    • Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med 2001; 46: 545-549
    • (2001) J Reprod Med , vol.46 , pp. 545-549
    • Schmid, G.1    Narcisi, E.2    Mosure, D.3    Secor, W.E.4    Higgins, J.5    Moreno, H.6
  • 8
    • 0029880026 scopus 로고    scopus 로고
    • Vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis
    • Narcisi EM, Secor WE. In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 1996; 40: 1121-1125
    • (1996) Antimicrob Agents Chemother , vol.40 , pp. 1121-1125
    • Narcisi, E.M.1    Secor, W.E.2
  • 9
    • 0035010668 scopus 로고    scopus 로고
    • Drug susceptibility testing of anaerobic protozoa
    • DOI 10.1128/AAC.45.6.1810-1814.2001
    • Upcroft J, Upcroft P. Drug susceptibility testing of the anaerobic protozoa. Antimicrob Agents Chemother 2001; 45: 1810-1814 doi: 10.1128/AAC.45.6.1810-1814.2001 (Pubitemid 32466353)
    • (2001) Antimicrobial Agents and Chemotherapy , vol.45 , Issue.6 , pp. 1810-1814
    • Upcroft, J.A.1    Upcroft, P.2
  • 10
    • 0027507920 scopus 로고
    • Metronidazole-resistant Trichomonas vaginalis in Brisbane
    • Voolmann T, Boreham P. Metronidazole-resistant Trichomonas vaginalis in Brisbane. Med J Aust 1993; 159: 490.
    • (1993) Med J Aust , vol.159 , pp. 490
    • Voolmann, T.1    Boreham, P.2
  • 11
    • 0035887675 scopus 로고    scopus 로고
    • Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis
    • DOI 10.1086/323034
    • Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis. Clin Infect Dis 2001; 33: 1341-1346 doi: 10.1086/323034 (Pubitemid 32955184)
    • (2001) Clinical Infectious Diseases , vol.33 , Issue.8 , pp. 1341-1346
    • Sobel, J.D.1    Nyirjesy, P.2    Brown, W.3
  • 12
    • 0037963656 scopus 로고    scopus 로고
    • Nitroheterocyclic drugs with broad spectrum activity
    • Raether W, Hanel H. Nitroheterocyclic drugs with broad spectrum activity. Parasitol Res 2003; 90: S19-39.
    • (2003) Parasitol Res , vol.90
    • Raether, W.1    Hanel, H.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.